Publication:
The relationship between serum fgf23 levels and liver steatosis in individuals with type 2 diabetes mellitus.

dc.contributor.authorBilgi K.
dc.contributor.authorGürsu M.
dc.contributor.authorSelek Ş.
dc.date.accessioned2026-03-08T21:36:23Z
dc.date.issued2021-01-01
dc.description.abstracthttps://hepatologyforum.org/storage/upload/pdfs/1614689070-en.pdf
dc.identifier.citationBilgi K., Gürsu M., Selek Ş., "The relationship between serum fgf23 levels and liver steatosis in individuals with type 2 diabetes mellitus.", Hepatology forum, sa.2, ss.7, 2021
dc.identifier.issn1307-5888
dc.identifier.issue2
dc.identifier.urihttps://hdl.handle.net/20.500.12645/41765
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectSağlık Bilimleri
dc.subjectHealth Sciences
dc.subjectKlinik Tıp (Med)
dc.subjectClinical Medicine (Med)
dc.titleThe relationship between serum fgf23 levels and liver steatosis in individuals with type 2 diabetes mellitus.
dc.typearticle
dspace.entity.typePublication
local.avesis.idcc4a6eea-1155-4d4b-b2fc-e35235f5e4d0

Files